Homology Medicines Price on February 23, 2023

FIXXDelisted Stock  USD 1.09  0.06  5.83%   
If you're considering investing in Homology Stock, it is important to understand the factors that can impact its price. As of today, the current price of Homology Medicines stands at 1.09, as last reported on the 1st of December, with the highest price reaching 1.10 and the lowest price hitting 1.02 during the day. We have found twenty-nine technical indicators for Homology Medicines, which you can use to evaluate the volatility of the firm. Please check out Homology Medicines' Risk Adjusted Performance of 0.0397, downside deviation of 4.11, and Market Risk Adjusted Performance of 0.2794 to validate if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Homology Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
FIXX
Based on monthly moving average Homology Medicines is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Homology Medicines by adding Homology Medicines to a well-diversified portfolio.

Homology Medicines Valuation on February 23, 2023

It is possible to determine the worth of Homology Medicines on a given historical date. On February 23, 2023 Homology was worth 1.35 at the beginning of the trading date compared to the closed value of 1.6. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Homology Medicines stock. Still, in general, we apply an absolute valuation method to find Homology Medicines' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Homology Medicines where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Homology Medicines' related companies.
 Open High Low Close Volume
  1.41    1.44    1.31    1.34    99,286  
02/23/2023
  1.35    1.73    1.35    1.60    348,622  
  1.57    1.60    1.38    1.39    200,826  
Backtest Homology Medicines  |  Homology Medicines History  |  Homology Medicines Valuation   PreviousNext  
Open Value
1.35
1.6
Closing Value
1.35
Upside

Homology Medicines Trading Date Momentum on February 23, 2023

On February 24 2023 Homology Medicines was traded for  1.39  at the closing time. The top price for the day was 1.60  and the lowest listed price was  1.38 . The trading volume for the day was 200.8 K. The trading history from February 24, 2023 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 13.13% . The trading delta at closing time against the current closing price is 12.50% .

Homology Medicines Fundamentals Correlations and Trends

By evaluating Homology Medicines' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Homology Medicines' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Homology financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Homology Medicines Stock history

Homology Medicines investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Homology is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Homology Medicines will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Homology Medicines stock prices may prove useful in developing a viable investing in Homology Medicines
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts. Homology Medicines operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 224 people.

Homology Medicines Stock Technical Analysis

Homology Medicines technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Homology Medicines technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Homology Medicines trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Homology Medicines Period Price Range

Low
December 1, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Homology Medicines cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Homology Medicines December 1, 2024 Market Strength

Market strength indicators help investors to evaluate how Homology Medicines stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Homology Medicines shares will generate the highest return on investment. By undertsting and applying Homology Medicines stock market strength indicators, traders can identify Homology Medicines entry and exit signals to maximize returns

Homology Medicines Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Homology Medicines' price direction in advance. Along with the technical and fundamental analysis of Homology Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Homology to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Consideration for investing in Homology Stock

If you are still planning to invest in Homology Medicines check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Homology Medicines' history and understand the potential risks before investing.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Transaction History
View history of all your transactions and understand their impact on performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance